Top 10 Companies in the Pyrantel Pamoate Market (2026): Market Leaders Powering Global Health

Pyrantel pamoate is an anthelmintic medication widely used to treat parasitic worm infections, including roundworms, hookworms, and pinworms, in both humans and animals. It is particularly effective in the treatment of gastrointestinal worm infestations. Pyrantel pamoate works by paralyzing the worms, which allows the body to expel them through bowel movements. It is commonly available in tablet and liquid forms and is used globally to combat parasitic infections.

The market for pyrantel pamoate involves its production, distribution, and sale in various forms and applications. The primary focus is on pharmaceutical companies producing pyrantel pamoate for medical treatments, especially in human health and veterinary care. This report provides an in-depth look into the market dynamics, trends, and factors influencing the growth and development of the global pyrantel pamoate market.

Pyrantel Pamoate Market – View in Detailed Research Report

Market Size

The Global pyrantel pamoate market was valued at USD 129 million in 2025 and is expected to reach USD 164.12 million by 2034, growing at a compound annual growth rate (CAGR) of 3.50% during the forecast period. The increasing prevalence of parasitic worm infections and a growing focus on healthcare in emerging markets contribute to this growth. The market is driven by the rising awareness about gastrointestinal parasitic infections and the demand for effective treatments in both humans and animals.

Product Definition

Pyrantel pamoate is an anthelmintic medication that effectively treats parasitic worm infections in humans and animals. It is available in tablet and liquid forms, making it convenient for both human and veterinary applications.

---

🔟 1. Uquifa

Headquarters: Beijing, China
Key Offering: Pyrantel pamoate tablets and capsules

Uquifa is a leading global pharmaceutical ingredient manufacturer with a strong presence in the anthelmintic market. The company focuses on high‑quality pyrantel pamoate production for both human and veterinary use, leveraging advanced manufacturing processes to ensure consistent purity and efficacy.

Sustainability & Growth Initiatives:

• Investment in green chemistry to reduce carbon footprint.
• Partnerships with veterinary associations to promote responsible deworming.
• Expansion into emerging markets through local production facilities.

---

🔟 2. Megafine

Headquarters: Mumbai, India
Key Offering: High‑purity pyrantel pamoate formulations

Megafine delivers premium pyrantel pamoate products tailored for both human and animal health sectors. The company emphasizes rigorous quality control and compliance with international regulatory standards.

Sustainability & Growth Initiatives:

• Adoption of renewable energy in manufacturing plants.
• Research into slow‑release delivery systems.
• Collaboration with local NGOs to improve access in rural areas.

---

🔟 3. Ipca Laboratories

Headquarters: Mumbai, India
Key Offering: Pyrantel pamoate for human and veterinary applications

Ipca Laboratories is a prominent Indian pharmaceutical company with a diversified portfolio. Its pyrantel pamoate line includes both tablet and liquid formulations, catering to global markets.

Sustainability & Growth Initiatives:

• Implementation of ISO 14001 environmental management systems.
• Investment in R&D for combination therapies.
• Strategic alliances with veterinary clinics worldwide.

---

🔟 4. Cosma

Headquarters: Madrid, Spain
Key Offering: Diverse pyrantel pamoate formulations

Cosma’s global reach allows it to supply pyrantel pamoate across multiple regions, offering both standard and high‑purity products for human and animal use.

Sustainability & Growth Initiatives:

• Focus on sustainable sourcing of active ingredients.
• Development of biodegradable packaging solutions.
• Expansion into EU and APAC markets through joint ventures.

---

🔟 5. Minsheng Medicine

Headquarters: Shanghai, China
Key Offering: Pyrantel pamoate tablets and capsules

Minsheng Medicine is a major manufacturer and distributor of pyrantel pamoate, with a strong presence in China and international markets. The company prioritizes high‑quality production standards.

Sustainability & Growth Initiatives:

• Implementation of waste‑reduction programs.
• Partnerships with veterinary associations for deworming campaigns.
• Investment in advanced production technologies.

---

🔟 6. Bayer

Headquarters: Leverkusen, Germany
Key Offering: Veterinary deworming solutions including pyrantel pamoate

Bayer’s veterinary portfolio includes pyrantel pamoate products that cater to a wide range of animal species, emphasizing safety and efficacy.

Sustainability & Growth Initiatives:

• Commitment to reduce greenhouse gas emissions.
• Development of eco‑friendly packaging.
• Collaborations with animal welfare organizations.

---

🔟 7. Pfizer

Headquarters: New York, USA
Key Offering: Human pyrantel pamoate formulations

Pfizer’s pyrantel pamoate line focuses on high‑purity, clinically tested products for human use, supported by robust clinical data.

Sustainability & Growth Initiatives:

• Investment in clean energy for manufacturing.
• Partnerships with public health agencies.
• Research into combination therapies.

---

🔟 8. Sanofi

Headquarters: Paris, France
Key Offering: Human and veterinary pyrantel pamoate products

Sanofi offers a range of pyrantel pamoate products that meet stringent regulatory standards, focusing on both human and animal health markets.

Sustainability & Growth Initiatives:

• Carbon neutrality targets for 2030.
• Investment in sustainable supply chains.
• Support for global deworming initiatives.

---

🔟 9. Merck

Headquarters: Darmstadt, Germany
Key Offering: Veterinary pyrantel pamoate solutions

Merck’s veterinary division provides high‑quality pyrantel pamoate products, emphasizing safety and efficacy across species.

Sustainability & Growth Initiatives:

• Energy efficiency upgrades in production facilities.
• Partnerships with animal health NGOs.
• Development of eco‑friendly formulations.

---

🔟 10. GlaxoSmithKline (GSK)

Headquarters: Brentford, UK
Key Offering: Human pyrantel pamoate tablets

GSK’s pyrantel pamoate line is designed for high‑purity human use, supported by extensive clinical research and regulatory approvals.

Sustainability & Growth Initiatives:

• Commitment to zero waste to landfill.
• Investment in renewable energy.
• Support for global health programs.

---

Download FREE Sample Report: https://www.24chemicalresearch.com/download-sample/286872/global-pyrantel-pamoate-forecast-market-2025-2032-325

Get Full Report Here: https://www.24chemicalresearch.com/reports/286872/global-pyrantel-pamoate-forecast-market-2025-2032-325

🌍 Outlook: The Future of Pyrantel Pamoate Market

The pyrantel pamoate market is poised for steady growth, driven by rising awareness of parasitic infections, expanding veterinary markets, and increasing healthcare investments in emerging economies. Regulatory advancements and innovative drug delivery systems are expected to further enhance market dynamics.

📈 Key Trends Shaping the Market:

• Expansion of veterinary care in emerging markets.
• Innovation in drug delivery forms such as slow‑release tablets.
• Increased focus on combination therapies for multi‑species use.
• Growing emphasis on sustainability and eco‑friendly packaging.
• Strategic collaborations between pharma and veterinary associations.

The companies listed above are not only leading the pyrantel pamoate market but are also driving the broader health and veterinary sectors toward more effective and sustainable solutions.